First, Chen et al. reported that METTL3 facilitates HCC tumorigenicity, growth and lung metastasis in vivo in an m6A-YTHDF2-dependent manner by promoting the degradation of suppressor of cytokine signaling 2 (SOCS2) mRNA (19). This evidence concerns the gene METTL3 and hepatocellular carcinoma.